SCHEMBL29759443

SCHEMBL29759443

CCCN[C@@H](Cc1ccc(O)c(O)c1)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM6B O15054 1/20 0.54
▸ KDM4E B2RXH2 6/20 0.53
▸ HSD17B10 Q99714 6/20 0.53
▸ ALOX15 P16050 5/20 0.53
▸ HIF1A Q16665 5/20 0.53
▸ TDP1 Q9NUW8 4/20 0.53
▸ RECQL P46063 3/20 0.53
▸ USP2 O75604 2/20 0.53
▸ ADORA3 P0DMS8 2/20 0.53
▸ HTR2A P28223 2/20 0.53
▸ PTGS2 P35354 2/20 0.53
▸ LCK P06239 2/20 0.53
▸ PTGS1 P23219 2/20 0.53
▸ EGFR P00533 1/20 0.53
▸ FYN P06241 1/20 0.53
▸ SLC7A5 Q01650 1/20 0.53
▸ MME P08473 1/20 0.51
▸ ACE P12821 1/20 0.51
▸ CA1 P00915 3/20 0.50
▸ CA2 P00918 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22364280 1.00 KDM6B (0.54) KDM6BKDM4EHSD17B10ALOX15HIF1A
SCHEMBL29926699 0.92 KDM6B (0.51) KDM6BKDM4EHSD17B10ALOX15HIF1A
SCHEMBL31028433 0.92 KDM6B (0.51) KDM6BKDM4EHSD17B10ALOX15HIF1A
SCHEMBL8519244 0.90 TRPV1 (0.54) KDM6BKDM4EHSD17B10ALOX15HIF1A
SCHEMBL6574091 0.90 TRPV1 (0.54) KDM6BKDM4EHSD17B10ALOX15HIF1A
SCHEMBL29652186 0.89 TRPV1 (0.56) KDM6BKDM4EHSD17B10ALOX15HIF1A
SCHEMBL31268016 0.89 TRPV1 (0.56) KDM6BKDM4EHSD17B10ALOX15HIF1A
SCHEMBL7433937 0.88 KDM6B (0.57) KDM6BKDM4EHSD17B10ALOX15HIF1A
SCHEMBL22364281 0.88 KDM6B (0.57) KDM6BKDM4EHSD17B10ALOX15HIF1A
SCHEMBL29700186 0.88 KDM6B (0.57) KDM6BKDM4EHSD17B10ALOX15HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108107205-B Method and system for high-throughput rapid screening of positive hybridoma cells 南京凌芯生物科技有限公司 2023-10-27 — — CN claimed
CN-108102913-B Three-dimensional cell culture chip based on soft lithography technology, preparation method and application thereof 南京凌芯生物科技有限公司 2023-10-27 — — CN claimed
CN-108107205-B Method and system for high-throughput rapid screening of positive hybridoma cells 南京凌芯生物科技有限公司 2023-10-27 — — CN disclosed
CN-108102913-B Three-dimensional cell culture chip based on soft lithography technology, preparation method and application thereof 南京凌芯生物科技有限公司 2023-10-27 — — CN disclosed
EP-3541368-B1 IMAGEABLE PARTICLES, METHODS OF MAKING AND METHODS OF USE THEREOF US HEALTH (US) 2023-07-12 — — EP disclosed
US-11382990-B2 Imageable polymers, methods of making and methods of use thereof THE USA, AS REPRESENTED BY THE SECRETARY, DHHS (US) 2022-07-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11382990-B2 Imageable polymers, methods of making and methods of use thereof PUF60, PBRM1, PCBP1 KDM6B 591/4885KDM4E 1954/4885HSD17B10 4669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback